These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6621183)

  • 21. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children.
    Paxton JW; Aman MG; Werry JS
    Epilepsia; 1983 Dec; 24(6):716-24. PubMed ID: 6641647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of saliva in home monitoring of carbamazepine levels.
    Rosenthal E; Hoffer E; Ben-Aryeh H; Badarni S; Benderly A; Hemli Y
    Epilepsia; 1995 Jan; 36(1):72-4. PubMed ID: 8001513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alteration in chromogranin A, obestatin and total ghrelin levels of saliva and serum in epilepsy cases.
    Dag E; Aydin S; Ozkan Y; Erman F; Dagli AF; Gurger M
    Peptides; 2010 May; 31(5):932-7. PubMed ID: 20172008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
    Gidal BE; Spencer NW; Maly MM; Pitterle ME
    Epilepsia; 1996 Apr; 37(4):381-5. PubMed ID: 8603645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary theophylline monitoring in asthmatic children.
    Orłowski L; Paczkowski D; Podleśny J
    Pol J Pharmacol Pharm; 1987; 39(2):173-6. PubMed ID: 3432165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbamazepine 10,11-epoxide in children.
    Rylance GW; Edwards C; Gard PR
    Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatography.
    Paxton JW
    Epilepsia; 1982 Apr; 23(2):185-9. PubMed ID: 7042328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of phenytoin and carbamazepine in an ultrafiltrate of saliva.
    Schramm W; Annesley TM; Siegel GJ; Sackellares JC; Smith RH
    Ther Drug Monit; 1991 Sep; 13(5):452-60. PubMed ID: 1957339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 24 hour variation of salivary carbamazepine and carbamazepine-10,11-epoxide concentrations in children with epilepsy.
    Bäckman E; Dahlström G; Eeg-Olofsson O; Bertler A
    Pediatr Neurol; 1987; 3(6):327-30. PubMed ID: 3149473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of serum carbamazepine concentration using dried blood spot specimens for resource-limited settings.
    Das S; Fleming DH; Mathew BS; Winston A B; Prabhakar AT; Alexander M
    Hosp Pract (1995); 2017 Apr; 45(2):46-50. PubMed ID: 28353375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring prednisolone and prednisone in saliva: a population pharmacokinetic approach in healthy volunteers.
    Teeninga N; Guan Z; Freijer J; Ruiter AF; Ackermans MT; Kist-van Holthe JE; van Gelder T; Nauta J
    Ther Drug Monit; 2013 Aug; 35(4):485-92. PubMed ID: 23783167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamazepine and carbamazepine-epoxide serum protein binding in newborn infants.
    Groce JB; Casto DT; Gal P
    Ther Drug Monit; 1985; 7(3):274-6. PubMed ID: 4049463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of saliva for monitoring oxcarbazepine therapy in epileptic patients.
    Klitgaard NA; Kristensen O
    Eur J Clin Pharmacol; 1986; 31(1):91-4. PubMed ID: 3780834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
    Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
    J Clin Pharmacol; 1993 Sep; 33(9):851-5. PubMed ID: 8227483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications in correlation studies between serum, free serum and saliva concentrations of nitrazepam.
    Hart BJ; Wilting J; de Gier JJ
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):127-31. PubMed ID: 3586770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the verapamil concentration of human blood serum and saliva].
    Rumiantsev DO; Piotrovskiĭ VK; Riabokon' OS; Metelitsa VI
    Farmakol Toksikol; 1987; 50(1):85-9. PubMed ID: 3556560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of saliva in monitoring carbamazepine medication in epileptic children.
    Bartels H; Oldigs HD; Günther E
    Eur J Pediatr; 1977 Aug; 126(1-2):37-44. PubMed ID: 902662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
    Johannessen SI; Gerna M; Bakke J; Strandjord RE; Morselli PL
    Br J Clin Pharmacol; 1976 Aug; 3(4):575-82. PubMed ID: 22216497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saliva and serum lacosamide concentrations in patients with epilepsy.
    Greenaway C; Ratnaraj N; Sander JW; Patsalos PN
    Epilepsia; 2011 Feb; 52(2):258-63. PubMed ID: 20946125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.